Citations in impact factor journals
Melanoma inhibition by cyclooxygenase inhibitors Medical Oncology Vol. 24, Issue 1, 1, 2007 |
Cyclooxygenase-2 in multiple myeloma: prognostic factor or therapeutic target? ? Response to Owen et al British Journal of Haematology Vol. 136, Issue 1, 165, 2007 |
Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects European Journal of Cancer Care Vol. 16, Issue 4, 351, 2007 |
Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines : Glioblastoma treatment adjunct British Journal of Pharmacology Vol. 161, Issue 3, 481, 2010 |
Can the therapeutic effects of temozolomide be potentiated by stimulating AMP-activated protein kinase with olanzepine and metformin? : Olanzapine augmentation of temozolomide British Journal of Pharmacology Vol. 164, Issue 5, 1393, 2011 |
Citation to this article as recorded by
Attitalla, I.H., 2011. Anti-colon activity in ethanolic extract of Phytolacca americana. Pak. J. Biol. Sci., 14: 914-915. CrossRefDirect Link |
Vyas, A., S.K. Das, D. Singh, A. Sonker, B. Gidwani, V. Jain and M. Singh, 2012. Recent nanoparticulate approaches of drug delivery for skin cancer. Trends Applied Sci. Res., 7: 620-635. CrossRef |
Citation to this article as recorded by
Anti-Colon Activity in Ethanolic Extract of Phytolacca americana Pakistan Journal of Biological Sciences Vol. 14, Issue 19, 914, 2011 |
How to cite this article
R.E. Kast and E.L. Altschuler, 2006. Current Drugs Available Now for Interleukin-6 Suppression as Treatment Adjunct in Glioblastoma: Anakinra, Aprepitant, Mirtazapine and Olanzapine. International Journal of Cancer Research, 2: 303-314.
DOI: 10.3923/ijcr.2006.303.314
URL: https://scialert.net/abstract/?doi=ijcr.2006.303.314
DOI: 10.3923/ijcr.2006.303.314
URL: https://scialert.net/abstract/?doi=ijcr.2006.303.314